Yu‐Li Lo
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 13
- Advanced biosensing and bioanalysis techniques 6
- Oncology 18
- Drug Transport and Resistance Mechanisms 13
- Co-authors
- Jin‐ding Huang (1 shared paper)Anya Maan-Yuh Lin (7 shared papers)Jui‐Chen Tsai (4 shared papers)Hsiang‐Tsui Wang (5 shared papers)Yueh‐Erh Rahman (3 shared papers)Hsin‐Ell Wang (1 shared paper)Jin Huang (2 shared papers)Yu Liu (1 shared paper)
- Journals
- International Journal of Molecular Sciences (5 papers)Scientific Reports (4 papers)Journal of Controlled Release (4 papers)Biomedicine & Pharmacotherapy (3 papers)Pharmaceutics (3 papers)
- Partner nations
- TaiwanUnited StatesCzechia
In The Last Decade
Yu‐Li Lo
62 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 120
- Pharmaceutical Science 477
- Biomaterials 386
- Oncology 450
- Molecular Medicine 71
- Molecular Biology 826
Countries citing papers authored by Yu‐Li Lo
This map shows the geographic impact of Yu‐Li Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Li Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Li Lo more than expected).
Fields of papers citing papers by Yu‐Li Lo
This network shows the impact of papers produced by Yu‐Li Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Li Lo. The network helps show where Yu‐Li Lo may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu‐Li Lo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 204 | |
| 2 | 2019 | 135 | |
| 3 | 2000 | 101 | |
| 4 | 2006 | 72 | |
| 5 | 2003 | 71 | |
| 6 | 2000 | 61 | |
| 7 | 2013 | 57 | |
| 8 | 2019 | 48 | |
| 9 | 2017 | 47 | |
| 10 | 2021 | 47 | |
| 11 | 2008 | 46 | |
| 12 | 2019 | 44 | |
| 13 | 2020 | 43 | |
| 14 | 2012 | 43 | |
| 15 | 2017 | 43 | |
| 16 | 2017 | 42 | |
| 17 | 2002 | 41 | |
| 18 | 1995 | 38 | |
| 19 | 2014 | 37 | |
| 20 | 2013 | 37 |
About Yu‐Li Lo
Yu‐Li Lo is a scholar working on Molecular Biology, Oncology, Biomaterials, Pharmaceutical Science and Epidemiology, having authored 63 papers that have together received 1.9k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (13 papers), Drug Transport and Resistance Mechanisms (13 papers), Nanoparticle-Based Drug Delivery (11 papers), Advanced Drug Delivery Systems (8 papers), Advanced biosensing and bioanalysis techniques (6 papers), Advancements in Transdermal Drug Delivery (5 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Pharmaceutical Science (477 citations), Biomaterials (386 citations), Oncology (450 citations), Molecular Medicine (71 citations) and Molecular Biology (826 citations). Yu‐Li Lo has collaborated with scholars based in Taiwan, United States and Czechia. Frequent co-authors include Jin‐ding Huang, Anya Maan-Yuh Lin, Jui‐Chen Tsai, Hsiang‐Tsui Wang, Yueh‐Erh Rahman, Hsin‐Ell Wang, Jin Huang, Yu Liu, Hong‐Ru Lin and Chih-Hsien Chang. Their work appears in journals such as International Journal of Molecular Sciences, Scientific Reports, Journal of Controlled Release, Biomedicine & Pharmacotherapy and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.